United States: FTC's Campaign Against Improper Orange Book Listings Continues With Amicus Brief In Teva's Challenge Of Amneal Asthma Inhaler ANDA - Sheppard Mullin Richter & Hampton
Thursday, 11 April 2024 ()
The Federal Trade Commission ("FTC") has filed an amicus brief in Teva Branded Pharmaceuticals Products R&D, Inc. v. Amneal Pharmaceuticals of New York, LLC to further the agency's...
|
||||
You Might Like |
||||
